BioCentury
ARTICLE | Financial News

CRISPR Therapeutics completes venture financing

April 28, 2014 7:00 AM UTC

CRISPR Therapeutics AG, Basel, Switzerland Business: Gene/Cell therapy Date completed: 4/24/14 Type: Venture financing Raised: $25 million Investor: Versant Ventures ...